Nanoparticles for cancer therapy: current progress and challenges

S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Nanoparticles in cancer treatment: opportunities and obstacles

R Awasthi, A Roseblade, PM Hansbro… - Current drug …, 2018 - ingentaconnect.com
In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7
million. Historically, combination chemotherapy has been the primary choice of treatment …

Nanodrug delivery in reversing multidrug resistance in cancer cells

S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …

Overcoming multidrug resistance in cancer stem cells

K Moitra - BioMed research international, 2015 - Wiley Online Library
The principle mechanism of protection of stem cells is through the expression of ATP‐
binding cassette (ABC) transporters. These transporters serve as the guardians of the stem …

Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

SM Espinoza, HI Patil… - … Journal of Polymeric …, 2020 - Taylor & Francis
Abstract Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past
few years. It is widely explored in drug delivery, where the development of nanomedicines …

Poly (ϵ-caprolactone) microcapsules and nanocapsules in drug delivery

AR Pohlmann, FN Fonseca, K Paese… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Poly (ϵ-caprolactone)(PCL), a biodegradable and biocompatible polymer, is
useful to encapsulate a wide range of drugs making it an interesting material for the …

Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects

K Coradini, FO Lima, CM Oliveira, PS Chaves… - European journal of …, 2014 - Elsevier
Resveratrol and curcumin are natural antioxidants found in the human diet that have been
used in the prevention and treatment of different diseases associated with oxidative stress …

[HTML][HTML] Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery

FA Bruinsmann, S Pigana, T Aguirre, G Dadalt Souto… - Pharmaceutics, 2019 - mdpi.com
Drug delivery to the brain represents a challenge, especially in the therapy of central
nervous system malignancies. Simvastatin (SVT), as with other statins, has shown potential …

Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: preclinical and clinical trials

FA Bruinsmann, G Richter Vaz… - Molecules, 2019 - mdpi.com
Glioblastoma (GBM) is the most lethal form of brain tumor, being characterized by the rapid
growth and invasion of the surrounding tissue. The current standard treatment for …